Trial ID or NCT#

NCT02424955

Status

RECRUITING

Purpose

The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion imaging for treatment planning, the prediction of therapy success, and to monitor the treatment response in patients with a primary or metastatic liver tumor undergoing radiation treatment.

Official Title

Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Dimitre Hristov
Aya Kamaya, MD
Radiologist
Associate Professor of Radiology (Body Imaging) at the Stanford University Medical Center
Daniel Chang, MD
Radiation oncologist
Sue and Bob McCollum Professor

Contact us to find out if this trial is right for you.

CONTACT

Rachel Freiberg
(650) 725-0438